Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
Covington
Argus Health
Queensland Health
UBS
Teva
Chubb
Novartis
Colorcon

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019634

« Back to Dashboard

NDA 019634 describes DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER, which is a drug marketed by B Braun and Miles and is included in three NDAs. It is available from one supplier. Additional details are available on the DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER profile page.

The generic ingredient in DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER is calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate. There are two hundred and seventy-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate profile page.
Suppliers and Packaging for NDA: 019634
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 019634 NDA B. Braun Medical Inc. 0264-7751 0264-7751-10 24 CONTAINER in 1 CASE (0264-7751-10) > 500 mL in 1 CONTAINER
DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 019634 NDA B. Braun Medical Inc. 0264-7751 0264-7751-00 12 CONTAINER in 1 CASE (0264-7751-00) > 1000 mL in 1 CONTAINER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/100ML;2.5GM/100ML;15MG/100ML;300MG/100ML;160MG/100ML
Approval Date:Feb 24, 1988TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength4MG/100ML;4GM/100ML;6MG/100ML;120MG/100ML;62MG/100ML
Approval Date:Feb 24, 1988TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/100ML;5GM/100ML;30MG/100ML;600MG/100ML;310MG/100ML
Approval Date:Feb 24, 1988TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
US Department of Justice
McKesson
Queensland Health
Chubb
Moodys
Deloitte
AstraZeneca
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot